Drreddys Laboratories | RDY - Ordinary Share Capital


Drreddys Laboratories reported INR833.07M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 63.31M 4.36M Jun/2026
Bayer EUR 982.42M 0 Sep/2026
Canopy Growth CAD 422.07M 53.78M Mar/2026
Cipla INR 807.87M 88K Sep/2026
Corcept Therapeutics USD 109.36M 1.44M Sep/2026
Drreddys Laboratories INR 833.07M 382K Sep/2026
GlaxoSmithKline GBP 2.02B 2.05B Sep/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Novartis USD 1.89B 12.09M Sep/2026
Pacira USD 39.9M 75K Sep/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.37M 53K Jun/2026
Richter Gedeon HUF 183.08M 215.04K Jun/2026
Sun Pharmaceuticals INR 2.4B 0 Sep/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
Teva Pharmaceutical Industries USD 1.17B 2M Sep/2026